文献速递淋巴瘤

特发性多中心型与单中心型Castleman病及滤泡树突状细胞肉瘤的下一代测序研究

Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
PubMed 文献 · Blood Adv · 2018-01-01

本研究对15例单中心型Castleman病(UCD)和3例特发性多中心型Castleman病(iMCD)行405基因靶向下一代测序,并对3例伴UCD透明血管型(UCD-HVV)的滤泡树突状细胞肉瘤(FDCS)行全外显子测序。1例iMCD和1例UCD见ETS1、PTPN6、TGFBR2共同扩增,该iMCD例另携DNMT3A L295Q体细胞突变并呈TAFRO临床亚型特征;1例UCD-HVV见6p组蛋白基因簇扩增;伴UCD-HVV的FDCS见已知癌基因、抑癌基因及染色质结构重塑蛋白的突变与拷贝数改变。

要点

  • 15例UCD与3例iMCD行405基因靶向测序,3例伴UCD-HVV的FDCS行全外显子测序。
  • 1例iMCD和1例UCD见ETS1、PTPN6、TGFBR2扩增,该iMCD例携DNMT3A L295Q突变。
  • 伴UCD-HVV的FDCS见癌基因、抑癌基因及染色质结构重塑蛋白的突变与拷贝数改变。

核心结论

  • UCD、iMCD及伴UCD-HVV的FDCS存在可检出的基因与表观遗传学改变,作者指出目前对这些罕见疾病遗传与表观遗传学图景的认识仍不足。

研究设计与样本

  • 对15例UCD和3例iMCD行靶向下一代测序(NGS;405个基因),对3例伴UCD透明血管型(UCD-HVV)的滤泡树突状细胞肉瘤(FDCS)行全外显子测序。

主要发现

  • 1例iMCD和1例UCD见ETS1、PTPN6、TGFBR2共同扩增。
  • 该iMCD病例还携体细胞DNMT3A L295Q突变,并呈Castleman-Kojima病(TAFRO)临床亚型的临床病理特征。
  • 1例UCD-HVV见6号染色体短臂(6p)组蛋白基因簇扩增。
  • 伴UCD-HVV的FDCS见已知癌基因、抑癌基因及染色质结构重塑蛋白的突变与拷贝数改变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Castleman disease (CD) is a rare lymphoproliferative disorder subclassified as unicentric CD (UCD) or multicentric CD (MCD) based on clinical features and the distribution of enlarged lymph nodes with characteristic histopathology. MCD can be further subtyped based on human herpes virus 8 (HHV8) infection into HHV8-associated MCD, HHV8-/idiopathic MCD (iMCD), and polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin change (POEMS)-associated MCD. In a subset of cases of UCD, an associated follicular dendritic cell sarcoma (FDCS) may be seen. Although numerous reports of the clinical and histologic features of UCD, MCD, and FDCS exist, an understanding of the genetic and epigenetic landscape of these rare diseases is lacking. Given this paucity of knowledge, we analyzed 15 cases of UCD and 3 cases of iMCD by targeted next-generation sequencing (NGS; 405 genes) and 3 cases of FDCS associated with UCD hyaline vascular variant (UCD-HVV) by whole-exome sequencing. Common amplifications of ETS1, PTPN6, and TGFBR2 were seen in 1 iMCD and 1 UCD case; the iMCD case also had a somatic DNMT3A L295Q mutation. This iMCD patient also showed clinicopathologic features consistent with a specific subtype known as Castleman-Kojima disease (thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly [TAFRO] clinical subtype). Additionally, 1 case of UCD-HVV showed amplification of the cluster of histone genes on chromosome 6p. FDCS associated with UCD-HVV showed mutations and copy number changes in known oncogenes, tumor suppressors, and chromatin structural-remodeling proteins.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Nagy A, Bhaduri A, Shahmarvand N, et al. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas. Blood Adv. 2018. PMID: 29496669. doi:10.1182/bloodadvances.2017009654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。